Tag Archives: The Economist

Americans are sicker, die younger while spending the most on health care; what South Korea can teach us.

The News: Typically, the more a developed country spends on health care, the longer its people live. The US, which spends the most on health care, defies that tendency another… Read more »



Obamacare signups ahead of last year; repealing ACA getting more problematic

The government says that more than a million people selected plans on the federal exchange during the first two weeks of open enrollment under the Affordable Care Act, indicating sign-ups… Read more »



Pfizer misses 3Q views but gets nod for Prevnar from China; Mao would scowl, but not Xi

More than a year after pulling its vaccines out of one of the world’s most challenging but lucrative drug markets, Pfizer has moved back into China with a thumbs up for top-selling… Read more »



Key Obamacare premiums to rise 25% next year; Great for insurers, but enrollees also win

Premiums for mid-level Obamacare health plans sold on the federal exchanges will see their biggest jump yet next year, another speed bump in the administration’s push for enrollment in the… Read more »



Obamacare Marketplace Expected to Shrink by 1.14 Million as Insurers Flee ACA; Lessons to Learn from Medicare?

An increasing number of people in Obamacare are learning that their health insurance plans won’t be available under the program next year, forcing them to find alternative coverage amidst dwindling… Read more »



Carmat Jumps after First Implantation of Bioprosthetic Artificial Heart; Says Device May Last “For Years.”

Carmat SA (Villacoublay FRA) announced that its artificial heart has been implanted for the first time in an important clinical study that may lead to European regulatory approval. It is similarly… Read more »



Pfizer Wins Bidding War for Medivation; But Why Bother?

Pharmaceutical giant Pfizer Inc. (New York City) is paying $14 billion to buy Medivation Inc. (San Francisco), a biotech company that sells a high-priced prostate cancer medication discovered by UCLA, according to the… Read more »



GE Healthcare Barges into Cell-Therapy Arena with Swiss Buy; Where’s the FDA?

GE Healthcare (Little Chalfont GBR) just signaled its intention to build a $1 billion business which offers specialized manufacturing tools for an upcoming tidal wave of cell therapies by acquiring… Read more »